An International Real-World Analysis of the Efficacy and Safety of Lorlatinib Through Early or Expanded Access Programs in Patients With Tyrosine Kinase Inhibitor–Refractory ALK-Po...

by Viola W. Zhu, Yen Ting Lin, Dong Wan Kim, Herbert H. Loong, Misako Nagasaka, Hao To, Yvonne Li En Ang, Chan Young Ock, Nishan Tchekmedyian, Sai Hong Ignatius Ou, Nicholas L. Syn, Thanyanan Reungwetwattana, Chia Chi Lin, Ross A. Soo
Published 2020

Trial Watch: Immunotherapeutic strategies on the horizon for hepatocellular carcinoma

by Benjamin Koh, Darren Jun Hao Tan, Wen Hui Lim, Jeffrey S L Wong, Cheng Han Ng, Kai En Chan, Meng Wang, Wei Peng Yong, Yock Young Dan, Louis Z Wang, Nigel Tan, Mark Muthiah, Alfred Kow, Nicholas L. Syn, Daniel Q. Huang, Thomas Yau
Published 2024